Burning Rock Announces Changes to Management and Board of Directors
Burning Rock Biotech (NASDAQ: BNR) announced significant changes in its management and Board of Directors on September 27, 2024. Mr. Leo Li has resigned from his positions as a director on the company's Board and as the Chief Financial Officer, effective immediately. Mr. Li confirmed that his resignation was due to personal reasons and not related to any disagreements with the company.
In light of this change, Ms. Xiaozhi Hu, senior director in finance, will take charge of financial operations, reporting, and related matters. Ms. Hu, who joined Burning Rock in May 2014, will report directly to Mr. Yusheng Han, the chairman of the board and CEO. Mr. Han expressed gratitude for Mr. Li's contributions, particularly during the company's IPO and subsequent business development projects.
Burning Rock Biotech (NASDAQ: BNR) ha annunciato significative modifiche nella sua gestione e nel Consiglio di Amministrazione il 27 settembre 2024. Il Sig. Leo Li si è dimesso dalle sue cariche di direttore nel Consiglio dell'azienda e di Chief Financial Officer, con effetto immediato. Il Sig. Li ha confermato che le sue dimissioni sono dovute a motivi personali e non sono legate a disaccordi con l'azienda.
Alla luce di questo cambiamento, La Sig.ra Xiaozhi Hu, direttrice senior delle finanze, si occuperà delle operazioni finanziarie, dei rapporti e delle questioni correlate. La Sig.ra Hu, che è entrata in Burning Rock nel maggio 2014, riferirà direttamente al Sig. Yusheng Han, presidente del consiglio e CEO. Il Sig. Han ha espresso gratitudine per i contributi del Sig. Li, in particolare durante l'IPO dell'azienda e i successivi progetti di sviluppo commerciale.
Burning Rock Biotech (NASDAQ: BNR) anunció cambios significativos en su gestión y en la Junta Directiva el 27 de septiembre de 2024. El Sr. Leo Li ha dimitido de sus cargos como director en la Junta de la compañía y como Director Financiero, con efecto inmediato. El Sr. Li confirmó que su dimisión se debió a razones personales y no a desacuerdos con la empresa.
A la luz de este cambio, La Sra. Xiaozhi Hu, directora senior de finanzas, se encargará de las operaciones financieras, informes y asuntos relacionados. La Sra. Hu, que se unió a Burning Rock en mayo de 2014, reportará directamente al Sr. Yusheng Han, presidente de la junta y CEO. El Sr. Han expresó su gratitud por las contribuciones del Sr. Li, especialmente durante la oferta pública inicial (IPO) de la empresa y los proyectos de desarrollo empresarial posteriores.
Burning Rock Biotech (NASDAQ: BNR)은 2024년 9월 27일에 경영진 및 이사회에 중요한 변화를 발표했습니다. 리오 리 씨는 회사 이사와 최고 재무 책임자(CFO) 직에서 즉시 사임했습니다. 리 씨는 그의 사임이 개인적인 사유 때문이며 회사와의 불화와는 관련이 없다고 확인했습니다.
이런 변화에 따라 샤오즈히 후 재무 선임 이사가 재무 운영, 보고 및 관련 업무를 담당하게 됩니다. 2014년 5월 Burning Rock에 합류한 후 씨는 융셩 한 이사회 의장 및 CEO에게 직접 보고할 것입니다. 한 의장은 리 씨의 기여, 특히 회사의 IPO와 이후 비즈니스 개발 프로젝트에 대한 감사의 말을 전했습니다.
Burning Rock Biotech (NASDAQ: BNR) a annoncé des changements significatifs dans sa direction et son Conseil d'Administration le 27 septembre 2024. M. Leo Li a démissionné de ses fonctions de directeur au sein du Conseil de l'entreprise et de Directeur Financier, avec effet immédiat. M. Li a confirmé que sa démission était due à des raisons personnelles et non à des désaccords avec l'entreprise.
À la lumière de ce changement, Mme Xiaozhi Hu, directrice senior des finances, prendra en charge les opérations financières, les rapports et les questions connexes. Mme Hu, qui a rejoint Burning Rock en mai 2014, fera rapport directement à M. Yusheng Han, le président du conseil et PDG. M. Han a exprimé sa gratitude pour les contributions de M. Li, notamment lors de l'introduction en bourse de l'entreprise et des projets de développement commercial ultérieurs.
Burning Rock Biotech (NASDAQ: BNR) kündigte am 27. September 2024 bedeutende Veränderungen in seiner Geschäftsführung und im Vorstand an. Herr Leo Li hat seine Positionen als Direktor im Vorstand des Unternehmens sowie als Chief Financial Officer mit sofortiger Wirkung niedergelegt. Herr Li bestätigte, dass sein Rücktritt aus persönlichen Gründen und nicht aufgrund von Meinungsverschiedenheiten mit der Firma erfolgte.
In Anbetracht dieser Veränderung wird Frau Xiaozhi Hu, Senior Director für Finanzen, die Verantwortung für die finanziellen Abläufe, Berichterstattung und damit verbundene Angelegenheiten übernehmen. Frau Hu, die im Mai 2014 zu Burning Rock kam, wird direkt an Herrn Yusheng Han, den Vorsitzenden des Vorstands und CEO, berichten. Herr Han sprach seine Dankbarkeit für die Beiträge von Herrn Li aus, insbesondere während des Börsengangs des Unternehmens und der anschließenden Geschäftsentwicklungsprojekte.
- Ms. Xiaozhi Hu, with extensive financial management experience, will take charge of financial operations
- Smooth transition in financial leadership with an internal promotion
- Resignation of CFO and board member Mr. Leo Li
- Potential disruption in financial leadership continuity
GUANGZHOU, China, Sept. 27, 2024 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR) (the “Company” or “Burning Rock”), a company focused on the application of next generation sequencing (NGS) technology in the field of precision oncology, today announced the resignation of Mr. Leo Li as a director from the Company’s board of directors (the “Board”) and as the Company’s chief financial officer, effective September 27, 2024.
Mr. Li has confirmed that his resignation was for personal reasons and not due to any disagreement with the Board, the Company or any of its affiliates on any matter relating to the Company’s operations, policies or practices. Mr. Li further confirmed that he has no claims against the Company whatsoever, whether in respect of fees, remuneration or compensation for loss of office.
Concurrently, Ms. Xiaozhi Hu, senior director in finance of the Company, will be in charge of financial operations, financial reporting and related matters of the Company, and report directly to Mr. Yusheng Han, chairman of the board and chief executive officer of the Company. Ms. Hu joined the Company in May 2014 and has extensive experience in financial management.
Mr. Yusheng Han, chairman of the board and chief executive officer of the Company, stated, “On behalf of Burning Rock, I would like to express my sincere gratitude to Mr. Leo Li for his contribution to the Company during the tenure of his service, particularly during the process of Company’s initial public offering and the subsequent business development projects. Leo has played a crucial role in enhancing Burning Rock’s performance in the capital markets as we achieved significant milestones. We respect his decision and sincerely wish Leo continued success in all his future endeavors.”
About Burning Rock
Burning Rock Biotech Limited (NASDAQ: BNR), whose mission is to guard life via science, focuses on the application of next generation sequencing (NGS) technology in the field of precision oncology. Its business consists of i) NGS-based therapy selection testing for late-stage cancer patients, and ii) cancer early detection, which has moved beyond proof-of-concept R&D into the clinical validation stage.
For more information about Burning Rock, please visit: ir.brbiotech.com.
Safe Harbor Statement
This press release contains forward-looking statements. These statements constitute “forward-looking” statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and as defined in the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by terminology such as “will,” “expects,” “anticipates,” “future,” “intends,” “plans,” “believes,” “estimates,” “target,” “confident” and similar statements. Burning Rock may also make written or oral forward-looking statements in its periodic reports to the SEC, in its annual report to shareholders, in press releases and other written materials and in oral statements made by its officers, directors or employees to third parties. Statements that are not historical facts, including statements about Burning Rock’s beliefs and expectations, are forward-looking statements. Such statements are based upon management’s current expectations and current market and operating conditions, and relate to events that involve known or unknown risks, uncertainties and other factors, all of which are difficult to predict and many of which are beyond Burning Rock’s control. Forward-looking statements involve risks, uncertainties and other factors that could cause actual results to differ materially from those contained in any such statements. All information provided in this press release is as of the date of this press release, and Burning Rock does not undertake any obligation to update any forward-looking statement as a result of new information, future events or otherwise, except as required under applicable law.
Contact: IR@brbiotech.com
FAQ
Why did Leo Li resign from Burning Rock Biotech (BNR)?
Who will replace Leo Li as CFO of Burning Rock Biotech (BNR)?
When did the management changes at Burning Rock Biotech (BNR) take effect?
What was Leo Li's role in Burning Rock Biotech (BNR) before his resignation?
